pre-IPO PHARMA

COMPANY OVERVIEW

Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has two products in late stage clinical development.


LOCATION

  • San Diego, CA, USA

  • THERAPEUTIC AREAS

  • Infectious Disease

  • WEBSITE

    https://www.ansunbiopharma.com/


    CAREER WEBSITE

    https://www.ansunbiopharma.com/careers/


    SOCIAL MEDIA


    INVESTORS

    3e-bioventures-capital joincap=investment lilly-asia-ventures lyfe-capital matrix-partners-china oceanpine-capital sinopharm-healthcare-fund vi-ventures yuanming-capital


    PRESS RELEASES


    Dec 21, 2021

    K2bio Welcomes Ansun BioPharma Biotechnology research accelerator will house Ansun's Houston based projects.


    Aug 27, 2020

    HJB and Ansun Biopharma Enter Strategic Agreement on Biologics CMC Development and Manufacturing Partnership


    Apr 15, 2020

    Ansun Biopharma Enrolls First Patient in Proof of Concept Trial of DAS181 for the Treatment of COVID-19


    Apr 2, 2020

    Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment USA - English USA - Français USA - Deutsch USA - español


    May 28, 2019

    Ansun Biopharma Announces First Patient Enrolled In Phase 3 Clinical Trial Evaluating DAS181 In Hospitalized, Immunocompromised Patients With Lower Respiratory Tract Parainfluenza Virus Infection


    For More Press Releases


    Google Analytics Alternative